Bloom Public Health’s Post

Technologies That Will Reshape the Pharmaceutical Sector in 2024

In the ever-evolving landscape of the pharmaceutical industry, emerging markets have become a focal point for growth and expansion. As developed markets face challenges such as patent expirations and pricing pressures, pharmaceutical companies are increasingly turning their attention to the untapped potential of emerging economies. Within this context, generic drugs play a crucial role in providing affordable healthcare solutions to millions of people worldwide. https://lnkd.in/dPEzSEf

Discover how Riverbed’s AI-powered Observability platform can revolutionize productive innovation in the pharmaceutical industry. Watch the latest episode of the “Inside Observability for Industries” series now: https://rvbd.ly/3xJnAeg

Discover how Riverbed’s AI-powered Observability platform can revolutionize productive innovation in the pharmaceutical industry. Watch the latest episode of the “Inside Observability for Industries” series now: https://rvbd.ly/4cJ8x3m

As the pharmaceutical industry undergoes swift transformations, the future of pharmaceutical regulation in Kenya holds the potential to enhance drug #safety, #efficacy, and #accessibility for all. From advancements in technology to shifts in global policies, the trajectory points towards a positive evolution in how drugs are overseen and made available to the public. #PharmaceuticalRegulation #DrugSafety #Efficacy #Accessibility #GlobalPolicies #CuttingEdgeTechnologies

Discover how Riverbed’s AI-powered Observability platform can revolutionize productive innovation in the pharmaceutical industry. Watch the latest episode of the “Inside Observability for Industries” series now: https://rvbd.ly/3zCnshk

“The pharmaceutical industry is on the cusp of a significant transformation as we move into 2024. The nature of the drugs hitting the market is changing. Personalized medicine, targeted therapy, digital therapies, and other specialty treatments are increasing in approvals,” says IMD. Do you agree? If you work in bio pharma then what you think is important. Please use the Comment option below to let me know. I am genuinely interested to learn more from you about this. Source: ‘Future Readiness Indicator: Pharmaceutical 2023’, published by IMD - International Institute for Management Development. https://lnkd.in/eEqK-X5n #pharmaceuticals #pharma #pharmaindustry #biopharma #futurereadiness #IMD #research #drugdevelopment #pharmapipeline #pipeline #regulatorycompliance #regulation

The pharmaceutical industry represents a strategic sector for economically and socially advanced countries because on the one hand it guarantees products at the service of citizens, on the other hand it is a highly innovative and profitable sector. To remain competitive, pharmaceutical companies must constantly invest in technological innovation, both to improve the effectiveness of existing drugs and to create new ones, and thus respond to the constant demand for medical care around the world. Recently, pharmaceutical companies have made large investments in sustainability. In Italy over the last 10 years, in fact, companies operating in this sector have reduced their energy consumption by 59% and greenhouse gas emissions by 32%. Stay tuned to find out how we contribute to achieving these goals: https://ow.ly/9SCn50Srvie #pharmaceutical #oursolutions #climaveneta

Discover how Riverbed’s AI-powered Observability platform can revolutionize productive innovation in the pharmaceutical industry. Watch the latest episode of the “Inside Observability for Industries” series now: https://rvbd.ly/3zBstGR

In a new report, the National Association of Manufacturers - NAM, a PULSE partner, examines the pharmaceutical industry’s significant commitment to R&D and its impact on our economy and our health. The findings of the report underscore the economic value of competition policy that incentivizes continued investment in the life sciences ecosystem. Such value includes: • More than $120 billion invested by the industry in R&D (2021) • 1.5 million jobs supported by pharmaceutical manufacturers • Contributing $355 billion in value-added output (2021) Read the full report text, and PULSE's key takeaways, here: https://lnkd.in/ekY2kK6u